Prof. Christopher Reid
Christopher Reid is a cardiovascular epidemiologist with appointments as Research Professor in both the School of Population Health at Curtin University and the School of Public Health and Preventive Medicine, Monash University. He was re-appointed as a John Curtin Distinguished Professor in 2021 and is currently Director of the Monash and Curtin Centre’s of Cardiovascular Research and Education (CCRE). He has been awarded over $178M as a Chief Investigator and has received continuous NHMRC funding since 2001. His major research interests include clinical outcome registries, randomized controlled trials, and epidemiological cohort studies. He has over 650 peer-reviewed publications, many of which are in leading journals including the New England Journal of Medicine, the Lancet, JAMA, JACC and the BMJ. He is a Chief Investigator for the Aspirin in Reducing Events in the Elderly (ASPREE) Study, the Statins in Reducing Events in the elderly Trial and the Australian arms of the HOPE-3, REACH and CLARIFY Registries. He is Chair of the Australian New Zealand Alliance for Cardiovascular Trials (ANZACT) Network and a Board Member of the Australian Clinical Trials Alliance and the Australian Cardiovascular Alliance.